| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Marquet Magda is a Director at IMMX, with reported holdings spanning 4 companies. Recent filings cover 5 purchases and 2 sales. Those positions are worth an estimated $1.9M at current prices.
Our model assigns Marquet Magda a middling insider score of 54/100, based on 5 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +7.3%.
Marquet Magda's largest disclosed position is in TRAX as Director, worth about $746K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | ANAB Anaptysbio, Inc | Director | Sale+OE | 11,000 | $48.23 | $530,531.29 | -33.8% | +51.4% | - | |
| Sep 6, 2023 | IMMX Immix Biopharma, Inc. | Director | Buy | 9,000 | $2.47 | $22,212.90 | +81.8% | +105.6% | -16.7% | |
| Sep 5, 2023 | IMMX Immix Biopharma, Inc. | Director | Buy | 10,000 | $2.47 | $24,722.00 | +1,000% | +105.3% | -17.8% | |
| Aug 31, 2023 | IMMX Immix Biopharma, Inc. | Director | Buy | 1,000 | $2.01 | $2,010.00 | New | +150.2% | +5.4% | |
| Dec 15, 2022 | ARCT Arcturus Therapeutics Holdings Inc. | Director | Buy | 2,222 | $18.00 | $39,996.00 | +9.8% | -12.6% | +58.3% | |
| Sep 13, 2019 | ARCT Arcturus Therapeutics Holdings Inc. | Director | Buy | 2,300 | $10.58 | $24,334.00 | +11.3% | - | - |